Securian Asset Management Inc. Has $3.47 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Securian Asset Management Inc. cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 4.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,056 shares of the company’s stock after selling 468 shares during the quarter. Securian Asset Management Inc.’s holdings in HCA Healthcare were worth $3,469,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Nuveen LLC bought a new stake in HCA Healthcare in the first quarter worth $569,217,000. Pacer Advisors Inc. boosted its holdings in HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after purchasing an additional 1,329,618 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after purchasing an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP bought a new stake in HCA Healthcare in the first quarter worth $164,835,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 0.4%

Shares of HCA opened at $431.62 on Wednesday. The stock has a market cap of $101.00 billion, a price-to-earnings ratio of 18.14, a P/E/G ratio of 1.37 and a beta of 1.40. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $439.01. The company has a 50-day moving average price of $411.88 and a two-hundred day moving average price of $379.69.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the company earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a dividend of $0.72 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on HCA. Barclays upped their price target on shares of HCA Healthcare from $390.00 to $445.00 and gave the company an “overweight” rating in a report on Thursday, September 18th. KeyCorp upped their price target on shares of HCA Healthcare from $370.00 to $465.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Royal Bank Of Canada decreased their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a report on Monday, July 28th. Robert W. Baird increased their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Finally, Wall Street Zen upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $437.19.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.